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Summary 
To determine whether CD38 and CD34 protelns have 
unique roles In TCR-dependent functions, chime& 
genes encoding the extracellular and transmembrane 
domains of the human IL-2 receptor a chain (Tat) fused 
to a cytoplasmlc domaln of either the CD3z or CD3< 
chain were introduced as transgenes into both normal 
and RAG2deficknt (RAGrh) mice. Developmental ar- 
rest of T lineage cells at the CD4, CD8 double-negative 
stage In the tmnsgenlc RAG1/- thymus was released 
to the CD4, CD8 double-posltlve (DP) stage by In vlvo 
cross-llnklng of TTE or TTY with antl-Tat antlbody. In 
TTc+ or TT&+, RAG2+ mice, In vitro cross-llnklng of 
TTE and TTY Induced DP thymocyte cell death and pro- 
liferation of mature slnglaposltlve T cells. Overall, no 
qualitative differences worn observed between TT&- 
and TTC-medlated functions, suggesting that dlffemnt 
CD3 components deliver qualltatlvely slmllar slgnals 
In Inducing TCR-dependent functions. 
Introduction 
The T cell receptor (TCR)-CDS complex for antigen com- 
prises at least six different transmembrane proteins: TCR 
a and 6 (or y and 6) and the invariant CD3 components, 
y, 8, E, and t; (for review see Ashwell and Klausner, 1990). 
The TCR-CD3 complex is critical for T cell development, 
as evidenced by studies of mice bearing functional TCRa8 
transgenes (for review see von Boehmer, 1990; Loh, 1991) 
and mice bearing targeted mutations of TCR chains (Phil- 
pott et al., 1992; Mombaerts et al., 1992b; ltohara et al., 
1993). In RAG-deficient mice (RAG+ mice) or SC/D mice, 
T cell maturation is blocked at the CD4CD8 double- 
negative (DN) stage (Bosma and Carroll, 1991, Mombaerts 
et al., 1992a; Shinkai et al., 1992). Introduction of a func- 
tionally rearranged TCR 6 chain but not a chain gene into 
RAG+ or SC/D mice rescues thymocyte development 
from the DN toCD4, CD8doublepositive(DP)stage(Kishi 
et al., 1991; Mombaettsetal., 1992b; Shinkai etal., 1993). 
Simultaneous introduction of functional 6 and a chain 
genes into the RAG’- background leads tofurtherdifferen- 
tiation of DP thymocytes into mature CD4 or CD8 single- 
positive (SP) T cells (von Boehmer, 1990; Shinkai et al., 
1993). 
CD3 components have been shown to be essential for 
the intracellular assembly and surface expression of the 
complete TCR-CD3 complex (for review see Klausner et 
al., 1990). Todissectthefunctionof individual CD3compo- 
nents in the TCR-CD3 complex, CD3 chimeric molecules 
containing a cytoplasmic domain of either the CD3s or 
CD% chain were generated and assayed for signaling 
functions in transfected T cell lines (Irving and Weiss, 
1991; Romeo and Seed, 1991; Letourneur and Klausner, 
1992; Wegener et al., 1992). These studies demonstrated 
that the CD3& and CDX chimeric molecules indepen- 
dently generated signals that mimicked endogenous TCR- 
mediated signals, suggesting that CD3 components were 
responsible for the TCR signal transduction. Recent analy- 
ses of CD3cdeficient mice demonstrated that CD31; was 
essential to the surface expression of the TCR-CD3 com- 
plex through T cell development, and important for TCR 
signal transduction (Love et al., 1993; Liu et al., 1993; 
Malissen et al., 1993; Ohno et al., 1993). 
Prior studies demonstrated that a conserved tyrosine- 
based activation motif (TAM) found in the cytoplasmic do- 
main of signal transduction molecules of TCR, immuno- 
globulin receptor and Fc receptor complexes (each CD3 
component, immunoglobulin-associated proteins Iga, Igp, 
FcR5, and FcRy) (Reth, 1989) was essential for CD3s- 
and CWC-mediated signal transduction (Letourneur and 
Klausner, 1992; Romeo et al., 1992; Wegener et al., 1992). 
Such studies were performed with established cell lines 
and therefore could not assess the roles of these CD3s 
and CD% in T cell development. It also remains unclear 
whether these two molecules perform identical functions 
in the context of TCR signaling. Therefore, we have intro- 
duced chimeric transgenes encoding extracellular and 
transmembrane domains of human interleukin 2 (IL-2) re- 
ceptor a chain (Tat) and the cytoplasmic domain of either 
the CD3& chain (?TE) or CD% chain (TR,) into both normal 
and RAG2+ mice(Letourneur and Klausner, 1991,1992). 
We have characterized the expression of lT& and lT( 
chimeric transgenic molecules and analyzed their ability 
to induce tyrosine phosphotylation of substrates upon 
cross-linking with anti-Tat antibody. We have then exam- 
ined the capacity of these chimeric molecules to mediate 
several TCR functions, including induction of thymocyte 
maturation from the DN to DP stage in transgenic RAGZ? 
mice; induction of cell death of DP thymocytes; and induc- 
tion of proliferation of mature SP T cells. 
Rewlts 
T Cell-Specific Expnrsslon of TTa and TTY 
In Trenegenlc Mice 
To study the function of CD~E- and CD3Qmediated signals 
with respect to T cell development, we generated trans- 
genie mice that harbored a transgene encoding the lT& 
or TTY chimeric molecule controlled by a ~56~ proximal 
promoter (Chaffin et al., 1990). Because the p5V proxi- 
mal promoter is selectively active in T lineage cells, it was 
expected that the expression of TT& and lTc would be 
restricted to T lineage cells in transgenic mice. It was also 
predicted that the expression level of lT& and TTY would 
Immunity 
402 
Table 1. T Cell-Specific Expression of TTE and lTS in Transgenic Lymphoid Cells 
Comparison of relative amount of CD3 
chimeric molecules and endogenous CD3c 
Percentage of chimeric 
complex on developmentally different stage 
molecule-positive 
of T cellsc 
Copy number 
Construct Line number Expression pattern cells in T-cells DN DP SP of transgene 
-ITS 3 T (DN-SP) 50-95 (%)” 00 w 94 w 42 WJ) -280 
23 T (DN-SP) 60-sv 80 09 37 -30 
24 T (DN-SP) >90 44 105 20 -80 
l-K 20 T (DN-SP) 50-w 111 133 51 -80 
35 T (DN-SP) >95 111 133 69 -70 
* From DN tc SP stage. 
b The variation may due to the heterolhomoxygosity of the transgene in these lines. 
c These values are the percentage of CD3 chime& molecules expressed on DN, DP, or SP T cells from each line of transgenic mice in normal 
or RAG2+ background as compared with the amount of endogenous DC3s complex on SP T cells (as llXt%). Percentage of endogenous CD3s 
complex expressed on DN and DP T cells is 3.3% and 3.3%, respectively. 
be higher in immature T ceils than in mature T cells due 
to the nature of the promoter. 
Three lines of lT&+ and two lines of TTY+ mice were 
generated, which contained from approximately 39-280 
copies of the transgenes (Table 1). We isolated thymo- 
cytes and splenocytes from transgenic or nontransgenic 
mice in the RAG2+(Figure la) or RAGi?‘- (Figure 1 b) back- 
ground, stained these cells with anti-human Tat antibody 
as well as antibodies to multiple murine T cell surface 
markers (i.e., CD2, CD4, CD8, CD25), and assayed sur- 
face expression of lT& and TTY chimeric molecules on 
various T cell subsets by FACS. These studies demon- 
strated that both chimeric molecules were expressed in 
T lineage cells from the DN to SP stage of T cell develop 
ment in all lines of transgenic mice (Figure 1; Table 1). 
Furthermore, both TTE and TTY were expressed at higher 
levels on immature T cells in the thymus than on mature 
T cells in thymus or peripheral lymphoid organs. Although 
a few CD2+ or Thyl.2+ cells were detectable in the thymus 
or spleen, respectively, of TTE+ or TTS+ transgenic mice 
in the RAGZ? background, these cells did not express 
TTE or TTY, and thus may not represent a conventional T 
lineage population (Figure 1 b). These staining profiles also 
demonstrated that the expression of chimeric molecules 
did not disturb lymphocyte development. In particular, T 
cell development remained arrested at the DN stage in 
TTE or TTt; tranSgWIiC mice in the RAG2+ background 
(Figure 1 b). 
To assess whether chimeric molecules associate with 
endogenous TCR components, transgenic or nontrans- 
genie total thymocytes in a normal background were sur- 
face biotinylated as described previously (Shinkai and Alt, 
1994). Surface labeled thymocytes were then lysed with 
1% digitonin, a solution that maintains interactions be- 
tween TCR and CD3 components. When lysates were im- 
munoprecipitated with antiCD3s (1452Cll) or anti-Tat 
(1 HT4-4H3) antibodies and separated in SDSPAGE un- 
der nonreducing and reducing conditions, the anti-CDb 
and anti-Tat antibodies immunoprecipitated only TCR- 
CD3 components and TTs or TTY, respectively (Figure 2; 
data not shown). The size of lT& (48 kDa) and lTt; (50 
kDa) proteins in nonreducing SDS-PAGE conditions indi- 
cate that both chimeric molecules are expressed on the 
surface as monomers and that the CD3 chimeric mole- 
cules are not physically associated with the endogenous 
TCR-CD3 complex in the cell membrane. Thus, CD3 chi- 
merit molecules and endogenous CD3 components ap 
pear to be physically independent. Cross-linking of chime- 
ric molecules with anti-Tat antibody should not activate 
endogenous CD3 or TCR-CD3 complexes. Similarly, anti- 
CD3s antibody should not activate CD3 chimeric mole- 
cules. 
To compare the relative expression levels of CD3 chime- 
ric molecules and endogenous CD3s at various develop 
mental stages of T cells, we stained thymocytes and 
splenocytes with antiCD4, antiCD8, antiCD3s, and anti- 
Tat antibodies, and analyzed the mean fluorescence in- 
tensity of lT&, TlX,, and endogenous CD~E on DN, DP, 
and SP T cells (Table 1). These comparisons showed that 
CD3 chimeric molecules were relatively more abundant 
at the DN-DP stages and less abundant at the mature SP 
stage when compared with endogenous CD3s, consistent 
with the preferential activity of the transgenic p56u proxi- 
mal promoter in immature T cells. 
induction of Tyroslne Phospholylatlon 
by TT& and TTL; 
To assay potential signaling functions of the chimeric mol- 
ecules in nontransformed cells, induction of tyrosine phos- 
phorylation in TTE or TTY transgenic thymocytes was 
analyzed. After cross-linking with anti-Tat or antiCD3s 
antibodies, thymocytes were lysed and protein tyrosine 
phosphorylation was examined in postnuclear cell lysates. 
Cross-linking of either TTE or TTY molecules with anti-Tat 
antibody induced tyrosine phosphorylation of many cellu- 
lar proteins (e.g., 110,80,70, and 35 kDa proteins) (Figure 
3). However, the patterns of phosphorylation induced by 
TTE and TTY were essentially identical. In addition, the 
pattern of tyrosine phosphotylation induced by cross- 
linking endogenous TCR-CD3 complexes with anti-CD3.s 
antibody was also indistinguishable from the patterns 
above. Thus, at this level of resolution, it appears that TTE, 
TT<, and endogenous TCR-CD3 complexes activate the 
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Figure 1. T Cell-Specific Expression of TTE and lT< in Trensgenic Mice 
FACS analysis of tranegenic or nontranegenic (wt) thymocytes and splenocytes in (A) normal, or (6) RAGP+ background. 
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Figure 2. Biochemical Analysis of ATE and lTc on DP Thymocytes 
Lysates of surface-biotinylated transgenic or nontransgenic (wt) DP 
thymocytes (2 x 10’) were subjected to immunoprecipitation with anti- 
CD3s (1462C1 l), anti-Tat (lHT44H3) or whole hamster IgG. The 
immunoprecipitates were separated by SDS-PAGE (12.5% polyacryl- 
amide) and transferred on the lmmunobilon membrane. The biotinyl- 
ated proteins were detected by horseradish peroxidase-streptavidin 
and the enhanced chemiluminence detection system. 
same signal transduction molecules in primary transgenic 
thymocytes. 
Induction of T Cell Development from the DN to DP 
Stage in the f?AG2+ Background by TTD and 
TTGMediated Signals 
It has been shown that TCRB chain expression can rescue 
T cell development from the DN to DP stage in /?A(? 
mice (Mombaerts et al., 1992b; Shinkai et al., 1993). It 
was also demonstrated that in vivo or in vitro treatment 
of RAG” DN thymocytes with anti-CD3c antibody induced 
this transition (Levelt et al., 1993; Jacobs et al., 1994; 
Shinkai and Alt, 1994), suggesting that TCR @ chain-medi- 
ated signals were transferred through the associated 
CD& complex. lmmunoprecipitation experiments using 
anti-CD& antibody showed association between CD3s, 
CD*, and CD36 chains in DN thymocytes from RAGY- 
mice (Shinkai and Alt, 1994). In addition, experiments us- 
ing either anti-CD& or ant&B antibody demonstrated as- 
sociation between TCRB with CD~E, CD*, and CD36 
chains in DP thymocytes from TCRfl transgenic RAG2+ 
mice (Shinkai et al., 1993). We failed to coprecipitate CD% 
(I$ chain in both these sets of experiments. Therefore, we 
asked whether a CD3L;mediated signal could rescue the 
DN to DP transition of T cell development in RAG2+ mice 
and whether the CD&-mediated signal alone could mimic 
the signal generated by an entire CD3s complex. 
We injected TTE or TTY transgenic RAG2+ mice with 
anti-Tat or anti-CD& antibody and then monitored CD4, 
CD8, mouse IL-2Ra chain, and CD2 expression on thymo- 
cytes harvested 1,2,2.5, and 8 days postinjection (Figure 
4), Restoration of thymocyte maturation from the DN to DP 
stage in anti-CD3 antibody-treated RAG2+ mice follows 
a progression from large IL-2Ra+, CDP DN cells (day 0 
postinjection) to large IL-2Ram, CD2+ DN cells (day 1) to 
IL-2Ra-, CD2+ CD4”“’ cells (day 2) to small IL-2Ra-, CD2+ 
DP cells (day 2.53) (Shinkai and Alt, 1994). In vivo treat- 
ment with anti-Tat antibody (200 pglmouse, one intraperi- 
toneal injection) rescued this transition in both lT& and 
rr7 transgenic RAGiF mice (Figure 4) but not in RAG2+ 
mice (data not shown). Thymic cellularity was also re- 
stored in both transgenic RAG2+ mice treated with anti- 
Tat in vivo (Figure 5). After 7 days of treatment with anti- 
Tat antibody, the total number of thymocytes in both 
transgenic RAGT’- mice was increased over 20- to lO& 
fold as seen in the anti-CD&-treated RAG2+ mice. How- 
ever, we found no evidence of further maturation to SP T 
cells in the thymus (see Figure 4) or peripheral lymphoid 
organs (data not shown) in either type of transgenic 
RAG2+ mice treated with anti-Tat antibody. 
Some subtle differences were obsenred between the 
endogenous CD3E complex and transgenic TTE- or m- 
mediated effects. For example, at 2 days (48 hr) postinjeo- 
tion of anti-Tat, CD4ti cells were not detected in either 
lT& or lTY transgenic RAG2’- mice, even though the ma- 
jority of their thymocytes had already matured into the 
CD2+, IL-2Ra- stage (see Figure 4). In addition, the ap 
pearance of 04, CD8 double dull-positive cells are fre- 
quently observed 2 days postinjection of anti-Tat in both 
lT& and lTY transgenic mice (more clearly seen in ATE, 
RAG2+ mice). 
Cell Death of DP Thymocytea Induced 
by TTE and TT~Mediated Signals 
Cross-linking of TCR-CD3 complex on immature DP thy- 
Figure 3. Induction of Protein Tymsine Phos- 
phorylation by lTs- or TT&Mediated Signals 
Tranagenic or nontransgenic (wl) DP thyrno- 
cytes were incubated with or without anMX3s 
or anti-Tat antibody for 15 min on ice, washed 
with cold phosphatebuffered saline, and then 
cross-linked with anti-mouse immunoglobulins 
(anti-Tat antibody-treated and nontreated cells) 
or anti-hamster immunoglobulins (antlCD3s 
antlbcdy-treated cells) for 0 and 3 min at 37OC. 
anti-CD3& anti-Tat After lysed cells, postnuclear cell lysates were separated by SDS-PAGE (12.5% po@zyl- 
amkle) and -onthemernbrane.phog 
phorylated tyrosines on the blot were detected by anti-protein tyrosine antibody 4010. This is representative of three independent experiments. 
In this experiment, the percentage of CD3 chimeric molecule-positive cells in total thymocytes was 0% (wt), 85% (ATE line 3), and 92% m 
line 35). 
;gll Development Controlled by CD3 Chimera 
RAGZ’- TTE,RAG~-‘- TT1;,RAG24- RAG24 TTqRAG2-‘- TTLRAG2-‘- 
-anti-CD%- -anti-Ta- 
TCR&RAG2-” 
Figure 4. Induction of the DN to DP Transition of ATE+ or m RAG2-+ Thymocytes by In Vivo Treatment of Anti-Tat Antibody 
Thymocytes fmm RAG+ mice treated with antiCDh antibody, ~E,RAG~+ (line 3) or lTU?AGP-+ (line 35) mice treated with anti-Tat antibody 
were examined for surface expression on CD& CD4 (left) and IL-2Ra, CD2 (right). In vivo treatment of antiCD3s into the transgenic RAG2+ mice 
gave same effect shown in the RAG2+ mice and anti-Tat did not induce any changes in nontransgenic ftAG2-+ mice. At each timepoint, we 
analyzed at least 2 mice in different antibody treatment. 
mocytes with antiCDb antibody induces programmed 
cell death and is believed to be related to the mechanism 
of negative selection during T cell development (Smith et 
al., 1989). An early characteristic change associated with 
DP thymocyte cell death induced by cross-linking of the 
TCR-CD3 complex is down-regulation of CD4 and CD8 
surface expression (Swat et al., 1991). To study the effects 
of lTs- and TT<-mediated signals upon programmed cell 
death, DP thymocytes from both transgenic or nontrans- 
genie mice in the normal background (RAG2+) were cul- 
tured with plate-bound anti-CD3c or anti-Tat antibody. 
Treatment of both lT&+ and TTY+ thymocytes for 20-24 
hr with either anti-CDhor anti-Tat antibody induced down 
modulation of CD4 and CD8 expression (Figure Sa). Re- 
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Figure 5. Recovery of RAGP Thymic Cellularity by Anti-Tat Anti- 
body In Vivo Treatment 
Total number of thymocytes from RAG2+ mice treated with antiCDh 
antibody or ATE+, RAGP (ATE line 3; lT& line 24), TTY+, RAG2+ PC; 
line 28; lT6 line 35) mice treated with anti-Tat antibody was plotted 
at g-3 days poettreatment. Average of total number of thymocytes at 
each timepoint was shown as a bar. Symbols are defined in the figure. 
covety of viable thymocytes was also reduced in lT& and 
TTY transgenic mice by anti-CD3 and anti-Tat antibody 
treatment (Figure 6b). Furthermore, induction of DNAfrag- 
mentation was observed in TT&+ and TTY+ mice by both 
antibody treatments (data not shown). Meanwhile, anti- 
Tat antibody treatment had no effect on nontransgenic 
(wild-type) thymocytes (Figures 6a, 6b). 
Proliferation of Mature SP T Cello by TTE 
and TT&-Mediated Signals 
To determine whether lT& and lT< stimulation could in- 
duce T cell proliferation of RAG+, mature SP T cells, we 
isolated total lymph node cells or purified SP T cells from 
TTE+ or TTY+ transgenic, or normal mice, and cultured 
them with anti-CDh or anti-Tat antibody. Platbbound 
antiCD3s induced T cell proliferation with or without exog- 
enous growth factors as a source of 11-2. Plate-bound anti- 
Tat antibody also induced proliferation of lT&+ and TTY 
T cells but not nontransgenic (wild-type) T cells in the pres- 
ence of these growth factors (Figures 7a, 7b). However, 
SP T cells from m and TTE transgenic mice failed to 
proliferate in response to anti-Tat stimulation unless exog- 
enous growth factors were added (except for lTc line 35, 
which responded at only 10% of the proliferation induced 
by antiCD3s antibody) (Figure 7a, 72 hr). We examined 
three different monoclonal antibodies against Tat, and all 
gave similar results (data not shown). 
We compared the proliferative responses of SP T cells 
from independent transgenic lines. By measuring the re- 
sponse to anti-Tat antibody, and standardizing against the 
response to anti-CDh antibody (which uniformly stimulate 
endogenous TCR-CD3 complexes in all lines; Figure 7a), 
we found anti-Tat antibody induced a greater degree of 
T cell proliferation in TTL than in TTE transgenic mice (Fig- 
ure 7b). 
Discussion 
Are There Any Functional Differames Between 
CD% and CDBQMediated Signals? 
To address the role of CD3s- and CD3c-mediated signaling 
in T cell development, we introduced two chimeric mole- 
cules bearing cytoplasmic domains of these proteins into 
transgenic mice and assayed them for TCRdependent 
functions at various stages of T cell development. 
By studying the pattern of tyrosine phosphorylation in 
transgenic TTE and TTY T cells induced by anti-Tat anti- 
body, and comparing this with the phosphorylation pattern 
induced bystimulatingendogenousTCR-CDScomplexes 
with antiCD3s antibody, we show that both transgenic 
17~ and TTY molecules function in a qualitatively similar 
fashion to the endogenous TCR-CD3 complex. While 
some previous studies suggested that ATE- and m-rnedi- 
ated signals could lead to distinct patterns of tyrosine 
phosphorylation (Letourneur and Klausner, 1992), several 
experimental differences between these prior studies and 
our current studies could explain the divergent results. 
First, differential regulation of signal transduction cas- 
cades in primary T cells versus cultured cell lines could 
lead to different phosphorylation responses. Second, the 
expression level of our transgenic molecules might differ 
from the levels of analogous molecules expressed in the 
earlier studies. Nevertheless, the similarity of phosphory- 
lation patterns induced by transgenic lT& and TTC mole- 
cules to those induced via endogenous TCR-CD3 com- 
plexes in our transgenic mice suggests that both CD3s 
and CD31; chains can associate with similar or identical 
receptor-associated kinases, and may transduce qualita- 
tively similar signals in vivo. 
Introduction of a functionally rearranged TCR 6 chain 
gene into RAG/- mice or cross-linking of CD3s molecules 
T Cell Development Controlled by CD3 Chimera 
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on RAG-” DN thymocytes induces maturation of DP from 
DN thymocytes, implicating the CD3s complex in signaling 
thistransition (Mombaertset al., 1992b; Leveltet al., 1993; 
Shinkai et al., 1993; Jacobs et al., 1994; Shinkai and Alt, 
1994). Biochemical analyses of TCRg-CDS complexes on 
TCRB transgenic RAG2+ DP thymocytes or of CD3s com- 
plexes on RAGP DN thymocytes failed to show physical 
association between these complexes and the CD3t;chain 
(Shinkai et al., 1993; Shinkai and Alt, 1994) raising the 
question of the role of the CD% chain during this stage 
Figure 6. induction of Thymocyte Cell Death 
by Anti-Tat Antibody Treatment 
(A) Tranegenic or nontranegenlc (wt) thymct 
cyt~ in nomral background were cultured for 
20-24 hr in anti-Tat or antLCD3~ antibody pre 
coated culture platw and examined the 8ur- 
face expression of CM end CD8. Each number 
showe the percentage of thymoqtee In the 
gated region. This la representative of at leaet 
two experiments In this experiment, the per- 
centage of DP thyrnocyte-exprwelng CD3 chi- 
merit mokule-poeitive cella in each trane- 
genie mouee wae 0% (wt), ge% (Tk line 3). 
end 34% (rrc line 28). 
(8)Thepercentageofrecoveryofvlablethym~ 
cytee treated with antlbody for 20-24 hr; lOIl% 
recovery was that from each thymocylee with- 
out antibody treatment. Each number wee av- 
erage of >2 different experiments. 
of T cell development. However, recent studies of CDSY- 
deficient mice suggested that CD% plays a role in thymo- 
cyte expansion during this stage of T cell development 
(Love et al., 1993; Liu et al., 1993; Malissen et al., 1993; 
Ohno et al., 1993). Furthermore, our in vivo cross-linking 
experiments clearly demonstrate that both ATE- and lTc- 
mediated signals can induce RAGT+ DN cells to differenti- 
ate into DP cells, as well as induce expansion of the total 
number of DP cells. These data support that idea that 
the CD3s transduces TCRB-mediated signals, and also 
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Figure 7. Proliferation of Mature SP T Cells by lT&- or T&mediated Signals 
(A) Proliferation of mature SP T cells from transgenic (IX line 3, TT< line 39) or nontransgenic (wt) mica were stimulated for 39 or 80 hr wlth or 
without anti-CD& or anti-Tat antibody in the absence or presence of exogenous growth factors purlfted from condltioned media of cultured rat 
splenocytes stimulated with concanavalin A, pulsed with PHjthyrnidine, further cultured 12 hr, and then harvested. This Is reprive of two 
experiments In this experiment, the percentage of CD3 chimeric rnoleculepo&tive cells in each purified SP T cells was 0% (wt), 97% (TTs line 
3) and 9996 (lTg line 35). 
(B) The percentage of proliferation of each transgenlc SP T cells by anti-Tat in the presence of the growth factors. The SP T cells were cuttured 
for 72 hr; 100% proliferation was the [3H)thyrnidlne incorporation of each tranegenic SP T cells stimulated with anti-CDL antibody in the presence 
of exogenous growth factors. 
suggest potential involvement of the CD% chain in either 
CD&z complex- or TCRB-CD3 complex-mediated signals 
controlling DN to DP transition. 
Immature DP cells respond to TCR engagement by un- 
dergoing apoptotic cell death (Smith et al., 1989). The 
mechanism by which DP cells are programmed to respond 
differently to engagement of the same antigen receptor 
that stimulates maturation of DN thymocytes is unclear. 
We have shown that both TTE- and T&mediated signals 
can induce down-regulation of CD4 and CD8 expression 
(a characteristic change of early DP thymocyte cell death; 
Swat et al., 1991) and subsequent cell death of DP cells. 
These data demonstrate that both CD3s and CD% cyto 
plasmic domains can provide this physiological signal at 
the appropriate developmental stage, and again, no signif- 
icant functional difference was noted between the two mol- 
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e&es. Furthermore, in mature SP T cells, both chimeric 
molecules were able to induce proliferation of SP T cells 
in the presence of exogenous growth factors. Therefore, 
we conclude that CD~E and CD% can deliver qualitatively 
similar signals for TCRdependent functions throughout 
T cell development. 
Are There Any Functlonal Dlfferencee Between 
Single CD%- or CD3~Medlated Signal and 
Multlchain TCR-CD3 Complex-Medieted Signals? 
We have found no differences in the pattern of tyrosine 
phosphorylation in the transgenic Tcells induced by these 
two chimeric molecules as compared with those induced 
by the endogenous TCR-CD3 complex. More importantly, 
no major differences between TTE or m and endogenous 
TCR-CD3 complex-mediated functions were found at vari- 
ous stages of T cell development, indicating that each 
CD3E or CD% chain can transduce qualitatively similar 
signals, which are generated by TCR. However, some sub- 
tle differences were observed. In particular, in vitro anti- 
CD3s but not anti-Tat antibody cross-linking efficiently in- 
duced SP TTE or lT( transgenic T cell proliferation in the 
absence of exogenous growth factors. 
Observed differences between endogenous and trans- 
genie chime& CD3 chain-mediated effects might simply 
be attributed to the use of different monoclonal antibodies 
for the particular treatments; however, this is unlikely be- 
cause two different anti-CD% and three different anti-Tat 
antibodies showed similar effects with respect to the prolif- 
eration of transgenic SP T cells (data not shown). Another 
possible explanation for observed differences is that other 
CD3 components, CD3y and CD%, may have unique roles 
for endogenous TCR-mediated signal transduction, or that 
the multiple CD3 components in the endogenous TCR- 
CD3 complexes may activate undetected signaling path- 
ways that are different from those activated by individual 
components. Yet another possibility is that the complete 
TCR-CD3 complex may activate a similar signaling path- 
way but with more efficiency or with different kinetics com- 
pared with single ATE or TTt; chimeric molecules. In this 
.context, clustering of CD3 chains may amplify the signal- 
ing efl iciency of the TCR-CD3 complex. Finally, it is possi- 
ble that the total number of TAM in activated TCR-CD3 
complex iscritical for the efficiency of the TCR signal trans- 
duction. Acorrelation of biological response with activated 
TAM contents has been observed. A truncated CD3< chi- 
merit molecule containing only one copy of the TAM dem- 
onstrated reduced signal transduction efficiency when 
compared with a complete CD% chimeric molecule bear- 
ing three copies of the TAM (Romeo et al., 1992). It was 
also shown that triplication of a single CD31; TAM in- 
creased the efficiency of signal transduction (Irving et al., 
1993). The Weaker proliferative response of lT&+ SP T 
cells versus l-K,+ SP T cells to cross-linking with anti-Tat 
antibody (Figure 7b) might also be dU8 to a difference in 
the total number of TAM in each chimeric molecule (one 
copy of TAM in each TT& molecule versus three copies 
in each lT6 molecule). 
Further studies will be required to clarify the precise 
roles of individual CD3 components in mediating signals 
from the multichain TCR-CD3 complex. However, our cur- 
rent studies clearly demonstrate that the signaling motifs 
of both CD& and CD% molecules individually can medi- 
ate signals that direct T cell development in vivo and imple- 
ment T cell function in vitro in a fashion similar to that 
generated by the complete TCR-CD3 complex. A similar 
conclusion has been proposed by a recent paper (Shores 
et al., 1994) after the submission of this work. 
ExperImental Procedures 
Vector Construction and Tmnsgenlc Mouse Production 
The constructs, TTE and lTY (provided by Drs. F. Letourneur and 
R. D. Klausner), which encode the chimeric proteins consisting of the 
extracellular and transmembrane domain of Tat and the cytoplasmlc 
domain of either CD~E or CD% chain, respectively (Letourneur and 
Klausner, 1991, 1992), were subcloned into the p5p proximal prc- 
mater expression vector, ~1017 (provided by Dr. R. M. Perlmutter) 
(Chaffln et al., 1990). The No+Notl fragments of these final constructs 
were injecW into M/CBA cccytes to generate transgenic mice. 
Transgenic positive animals were identified by hybridization to a probe 
encoding the Tat portion of chimeric molecules. Transgenic mice in 
RAGP background were established by crossing transgenic mice to 
RAGZY- mice. All mice used in this experiment were maintained in 
our animal facility. Any RAG2+ background mice were kept in the 
pathogen-free environment. 
Flew cytomelly Andysee 
The following antibodies were purchased from Pharmingen (San 
Diego, California): phycosrythrin (PE)-coupled RM2-1 (antiCD2) (Ya- 
gita et al., 1989), fluorescein isothiocyanate (FITC)-labeled 53-8 (anti- 
CDSa) (Ledbetter et al., 1980), PE-coupled RM4-5 (antiCD4), FITC- 
labeled 7D4 (anti-IL-2Ra) (Ortega et al., 1984), PEcoupled 53-2 
(anti-Thyl.2) (Ledbetter and Herzenberg, 1979). FITC-labeled 145- 
Xl 1 (antKD3a) (Leo et al., 1987). lHT4-4H3 (Fox ef al., 1985) were 
purified from as&es and labeled to FITC. Flow cytometry analysis 
was performed by standard method as described (Parks et al., 1988) 
using FACScan (Secton-Dickinson, Mountain View, California). FAC- 
Scan research software was used for analysis. 
Relative amounts of CD3 chimeric molecules and endogenous 
CD5 or TCR-CDI complex on developmentally different stages of T 
cells were determined as follows. Transgenic or nontransgenic thymo- 
cytes, splenocytes, or lymph node cells from normal or RAGr+ mice 
were stained with saturated amount of anti-CDh (145-2Cll) or anti- 
Tat (lHT44H3) labeled with FITC (still minimum background), PE- 
anti-CD4 and cychrome c-antiCD8. These stained cells were ana- 
lyzed by FACS. Mean fluorescence intensity of FITC on DN, DP, or 
SP subset was calculated as the following formula: 
mean channel fluorescence intensity of FITC on each T cell subset 
value of FITC/antibody (F/P) ratio 
In Vlvo Antlbody Traatment 
For the in vivo antibody treatment, antiCD3a and anti-Tat antibodies 
were used as a purified or ascites form. Mice were intraperitoneally 
injected with 200-300 pg, 0.5 ml antibody and analyzed l-8 days 
postinjection. 
In Vitro Thymocyte Culture 
Thymocytes were harvested from transgenic or nontransgenic mice 
in normal background, or from transgenic mice in RAG2+ background 
at day 8 postinjectiin of anliGD3a or anti-Tat antibody. Thymccytes 
(1 x 10’12 ml) were cultured in 8-well tissue culture plates, which were 
precoated with antibodies (10 ug/ml) for 30 min at 37OC, overnight at 
4OC and then washed with phosphaWbuffered saline twice before 
use. After 20-24 hr of culture a1 37OC in 5% COP, cells were harvested 
and analyzed for CD4 and CD8 expression. Recovery of viable cells 
was examined after lympholyle (Latxxatories Limited, Ontario, Can- 
ada) density preparation. 
Immunity 
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In Vitro Mature 1 Cdl Prv~llfemtion As8ay 
01 total lymph node cells (- 60%-70% Thy1 + cells) or purified T cells 
(>95% Thyl+ cells) by negative selection using goat anti-mouse IgG- 
coated magnetfc beads (DYNAL, Lake Success, New York), 2 x I@/ 
200 ul were cultured in the presence or absence of exogenous growth 
factors as a source of IL-2 in 96-well microtiter tissue culture plates 
precoated with antibodies for 36-60 hr at 37OC in 5% COn, pulsed in 
I uC/well of PH)thymidine for 12 hr and then harvested. The growth 
factors were purifted from conditioned media of cultured rat spleno 
cytes stimulated with concanavalin A (von Boehmer and Haas, 1961). 
Anatysls ol Protein lyroalne Phosphotytatlon 
Gf the thymocytes or purified T cells, 3 x 10 were incubated with 
antibodies for 15 min at 4OC and washed with DMEM without fetal 
calf serum. These treated cells were resuspended in 15 ul of DMEM. 
After 1 min at 37OC, 3 ul of anti-mouse or hamster antibodies (2-5 
ug) were loaded in the suspension, incubated for 3 min at 37OC and 
then the reaction was terminated by loading of 6 ul of 4 x SDS sample 
buffer solution. Cell lysates were micro centrifuged (1.3 x 10’ x g for 
15 min) after 30 min incubation at 4*C and supematant was collected. 
These samples were separated in 15% SDS-PAGE and transferred 
to the membrane, ImmobilonP (Millipore, Bedford, Massachusetts). 
Tytosine phosphory(atlon of transferred proteins were analyzed by 
anti-phosphotyrosine antibody 4610. 
ImmunopreclptMtlon 
lmmunoprecipitatlon of biitinytated cell surface proteins was per- 
formed as described previously (Shinkai and Al, 1994). In brief. 5 x 
IO’ cells were biotinylated with sulfoNHS biotin in (50 us/ml) 10 mM 
borate buffer solution @H 6.6) for 15 min at 20°C (5 x 107/ml) and 
then washed with 25 mM L-lysine phosphate-buffered saline three 
times. After the last wash, cells were lysed in a 1% digitonin lysis 
solution (1% digitonin, 60 mM HEPES IpH 7.41, 150 mM NaCI, 1 mM 
EDTA, 5 ugIml leupeptin, 5 @ml pep&tin, IO uglml pA-PMSF, and 
1 mM PMSF) on ice for 30 min and then microcentrifuged (1.3 x l(r 
x g for 15 min). Postnuclear supernatant was precleared by bovine 
serum albumin-coated Sepharose 68 for l-2 hr at 4OC and then incu- 
bated with various antibodies for 16 hr at 4OC. lmmunoprecipitates 
were separated in SDS-PAGE and transferred to ImmobilonP. Trans- 
ferred biitlnyiated proteins were detected by HRP-coupled strep 
tavidin-chemiluminence detection system (Amersham, Arlington 
Heights, Illinois). 
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